Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01050673 · ClinicalTrials.gov registry record · NA

Trial of Versajet Compared With Conventional Treatment in Acute and Chronic Wounds

A NA study of Surgical Wound Dehiscence, sponsored by Smith & Nephew.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01050673: Completed NA study of Surgical Wound Dehiscence, sponsored by Smith & Nephew.

NCT01050673 is a NA study of Surgical Wound Dehiscence that has completed, run by Smith & Nephew. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01050673, a NA study of Surgical Wound Dehiscence, has completed, sponsored by Smith & Nephew.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

It is increasingly recognised that the debridement of devitalised, bacterially contaminated or senescent tissue is an essential component of the effective treatment of delayed healing wounds. Whilst surgical debridement procedures have conventionally been performed with scalpels and other sharp instrumentation, alternative techniques such as the VERSAJET Hydrosurgery System are becoming more widespread. To increase the adoption of this new technology, it is essential that clinical improvements are assessed alongside the potential impact on the costs of debridement and the net financial impact on the hospital. It is hypothesised that a decrease in the time to achieve stable wound closure will not only lead to a patient benefit, but also a potential reduction in the cost of treatment due to e.g. repeat procedures, longer hospital stay, infection etc. The purpose of this study is to investigate the difference in time to closure of wounds surgically excised with VERSAJET Hydrosurgery System and those surgically excised using conventional operating room techniques.

Conditions Studied

Interventions

  • DEVICE VERSAJET
  • PROCEDURE Scalpel or blade

Study Locations (1)

Illinois

  • Northwestern University Feinberg School of Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2007-11
Est. Completion 2011-09
Phase NA
Smith & Nephew

72 total trials

What the finished NCT01050673 record still lists

NCT01050673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Surgical Wound Dehiscence appearing as the primary indexed condition, and to 2 interventions - of which VERSAJET is the first listed.

NCT01050673 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01050673 about?

NCT01050673 is a clinical study titled "Trial of Versajet Compared With Conventional Treatment in Acute and Chronic Wounds". It is increasingly recognised that the debridement of devitalised, bacterially contaminated or senescent tissue is an essential component of the effective treatment of delayed healing wounds. Whilst surgical debridement procedures have conventionally been performed with scalpels and other sharp ins...

What is the current status of trial NCT01050673?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-11. Estimated completion is 2011-09.

What conditions does trial NCT01050673 study?

This clinical trial studies the following conditions: Surgical Wound Dehiscence.

What interventions are being tested in trial NCT01050673?

The interventions under investigation include: VERSAJET (DEVICE), Scalpel or blade (PROCEDURE).

Who is sponsoring clinical trial NCT01050673?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01050673 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Wound Dehiscence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01050673's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01050673, the US trial registry maintained by the National Library of Medicine. NCT01050673 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.